Average Weight Loss with Mounjaro: What the Studies Say

How much weight can one truly lose with Mounjaro? A synthesis of all clinical data available in 2026.

The most frequent question from patients considering Mounjaro treatment is simple: how much will I lose? The answer, based on data from 8 major clinical trials involving over 20,000 patients, is more nuanced than a simple figure. Here is a comprehensive synthesis of tirzepatide weight loss results.

Average Weight Loss by Dose and Population

Results vary depending on the administered dose and the treated population. Here is a summary of data from SURMOUNT and SURPASS studies:

Study Population Dose Duration Weight Loss Weight Loss (avg. kg)
SURMOUNT-1 Obese non-diabetic 5 mg 72 wks. -15.0% -16 kg
SURMOUNT-1 Obese non-diabetic 10 mg 72 wks. -19.5% -21 kg
SURMOUNT-1 Obese non-diabetic 15 mg 72 wks. -20.9% -23 kg
SURMOUNT-2 Diabetic obese 15 mg 72 wks. -14.7% -14 kg
SURMOUNT-3 Post-intensive diet 15 mg 72 wks. -24.3%* -26 kg
SURMOUNT-4 Continuation max 88 wks. -25.3% -28 kg

*Total loss including the run-in phase with a hypocaloric diet

Factors Influencing Individual Weight Loss

Clinical study averages mask significant individual variability. Several factors influence treatment response:

  • Starting BMI: patients with a higher BMI generally lose more weight in absolute terms, but a similar percentage
  • Sex: women tend to lose slightly less weight than men in percentage, but differences are modest
  • Diabetic status: diabetic patients lose 5 to 6 percentage points less than non-diabetics
  • Dietary adherence: patients who follow nutritional recommendations lose significantly more
  • Physical activity: regular exercise (150+ min/week) increases weight loss by 2 to 4 percentage points
  • Dose achieved: each dose level (5, 10, 15 mg) provides additional benefit
  • Genetics: genetic variants in GLP-1 and GIP receptors modulate the response

Typical Weight Loss Timeline

Weight loss with tirzepatide follows a characteristic temporal profile:

  • Months 1-2 (2.5 mg): modest loss of 2 to 4 kg, mainly due to reduced appetite and gastrointestinal effects
  • Months 3-4 (5 mg): accelerated loss, approximately 1 to 1.5 kg/week in good responders
  • Months 5-9 (10-15 mg): phase of maximum loss, the curve is steepest
  • Months 9-12: gradual slowdown, onset of plateau in some patients
  • Months 12-18: weight stabilization in the majority of patients, with possible adjustments

Clinical Reality vs. Clinical Trials

Real-world evidence generally shows slightly lower results than clinical trials. A retrospective American study published in 2024 involving over 30,000 patients treated in routine practice reported an average weight loss of 15 to 17% at one year with tirzepatide, compared to 19-21% in SURMOUNT-1.

This difference is explained by several factors: imperfect adherence, treatment interruptions (stock shortages), absence of the structured follow-up of clinical trials, and more heterogeneous populations. Nevertheless, real-world results remain highly significant and superior to any other pharmacological treatment.

Tracking Tools to Optimize Your Results

Daily tracking of weight and habits is an independent factor for success. Patients who weigh themselves regularly and monitor their diet lose more weight. The MounjaGO app, available for 5€ for life (one-time payment, zero subscription) as a Web app — no installation required, with 100% local storage (maximum privacy), offers a comprehensive dashboard: weight tracking with evolution graphs, symptom journal, injection reminders, and PDF report generation for medical consultations.

FAQ: Weight Loss with Mounjaro

How much weight can one lose in the first month?
Generally, 2 to 4 kg in the first month at the 2.5 mg dose. Loss accelerates with dose increases. Some patients lose faster, others slower.

Is weight loss faster with Mounjaro than with Ozempic?
Yes. Studies consistently show 4 to 6 percentage points of additional weight loss with tirzepatide compared to semaglutide, representing approximately 5 to 7 kg difference over one year.

What if I’m not losing enough weight?
Talk to your doctor. Options include: increasing the dose if possible, checking adherence to lifestyle measures, looking for a medical cause of resistance, or considering a combination medication.